UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMPS
2376
DELISTED
Altus Power
AMPS
| $960K | ﹤0.01% |
301,788
-8,169
| -3% | -$29.1K |
|
|
TELL
2377
DELISTED
Tellurian Inc.
TELL
| $959K | ﹤0.01% |
990,357
-2,707,678
| -73% | -$2.34M |
|
|
VZIO
2378
DELISTED
VIZIO Holding Corp.
VZIO
| $958K | ﹤0.01% |
85,733
-10,136
| -11% | -$112K |
|
2379
BrightSpring Health Services
BTSG
$12.4B
| $955K | ﹤0.01% |
65,060
-17,305
| -21% | -$217K |
|
2380
NB Bancorp
NBBK
$989M
| $952K | ﹤0.01% |
+51,290
| New | +$907K |
|
2381
Theravance Biopharma
TBPH
$877M
| $947K | ﹤0.01% |
117,505
-21,372
| -15% | -$185K |
|
2382
First Community Bankshares
FCBC
$911M
| $946K | ﹤0.01% |
21,922
-4,149
| -16% | -$173K |
|
2383
Miller Industries
MLR
$619M
| $945K | ﹤0.01% |
+15,492
| New | +$931K |
|
2384
Riskified
RSKD
$716M
| $940K | ﹤0.01% |
198,757
-12,868
| -6% | -$70.3K |
|
|
NNDM
2385
Nano Dimension
NNDM
$343M
| $939K | ﹤0.01% |
383,189
+177,951
| +87% | +$401K |
|
2386
Arm
ARM
$302B
| $937K | ﹤0.01% |
6,550
+2,900
| +79% | +$412K |
|
2387
Heartland Express
HTLD
$956M
| $936K | ﹤0.01% |
76,259
-969
| -1% | -$11.9K |
|
2388
iShares MSCI Philippines ETF
EPHE
$148M
| $935K | ﹤0.01% |
+32,100
| New | +$855K |
|
2389
Ambev
ABEV
$46.4B
| $934K | ﹤0.01% |
382,600
+97,150
| +34% | +$218K |
|
2390
Sable Offshore Corp
SOC
$911M
| $927K | ﹤0.01% |
39,248
+3,531
| +10% | +$63.6K |
|
2391
The RMR Group
RMR
$332M
| $926K | ﹤0.01% |
36,496
+4,390
| +14% | +$108K |
|
2392
Mercer International
MERC
$39.8M
| $923K | ﹤0.01% |
136,283
+33,525
| +33% | +$232K |
|
2393
Farmers National Banc Corp
FMNB
$930M
| $922K | ﹤0.01% |
60,981
+466
| +0.8% | +$6.75K |
|
2394
indie Semiconductor
INDI
$854M
| $922K | ﹤0.01% |
230,975
-34,523
| -13% | -$168K |
|
2395
Universal Technical Institute
UTI
$1.59B
| $919K | ﹤0.01% |
56,504
-13,834
| -20% | -$237K |
|
2396
Disc Medicine
IRON
$2.97B
| $916K | ﹤0.01% |
18,649
+3,312
| +22% | +$155K |
|
2397
Merchants Bancorp
MBIN
$2.49B
| $914K | ﹤0.01% |
20,319
+1,099
| +6% | +$48.8K |
|
2398
Hyster-Yale Materials Handling
HY
$665M
| $913K | ﹤0.01% |
14,321
-1,760
| -11% | -$115K |
|
2399
Praxis Precision Medicines
PRAX
$10.1B
| $913K | ﹤0.01% |
15,868
-6,014
| -27% | -$325K |
|
2400
Taboola.com
TBLA
$1.11B
| $912K | ﹤0.01% |
271,398
-15,291
| -5% | -$50.4K |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.